Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Check-Cap and GE Healthcare announced the companies have achieved the initial milestone in their collaboration to develop high-volume, X-ray capsule manufacturing capabilities.
read more
Chartwell Pharmaceuticals has implemented software from Adents a provider of deployable serialization and track-and-trace software solutions for compliance with current and future track & trace deadlines.
read more
Wednesday, December 12, 2012
The Almac Group’s Clinical Technologies business unit is pleased to announce that Charlie Morris has joined the company as Vice President of New Products and Services. In this role, Mr. Morris will report directly to Jim Murphy, President of Almac ...
read more
Charleston Laboratories and Daiichi Sankyo have announced that a third Phase 3 clinical trial of CL-108, an opioid-containing formulation, met its primary endpoints.
read more
Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical.
read more
Friday, November 20, 2020
PathoQuest and Charles River has established a U.S. subsidiary, PathoQuest and will construct a next generation sequencing-based testing laboratory at Charles River’s site in Wayne, PA.
read more
Charles River Laboratories and PathoQuest announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS) services to the biologics industry.
read more
Charles River Laboratories has entered into an exclusive partnership with Fios Genomics, a provider of bioinformatics data analysis services.
read more
Wednesday, January 16, 2019
Charles River Laboratories has collaborated with Atomwise on integrated and artificial intelligence (AI)-driven drug discovery.
read more
Charles River Laboratories International, Inc. announced a contract development and manufacturing organization (CDMO) agreement to produce Good Manufacturing Practice- (GMP) plasmid DNA.
read more
Charles River Laboratories International, Inc. announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement. Ship of Theseus will leverage Charles River’s premier expertise to ...
read more
Charles River Laboratories announced the planned opening of the Charles River Accelerator and Development Lab (CRADL™) in South San Francisco in early 2020.
read more
Thursday, October 21, 2021
Charles River Laboratories announced the expansion of its Charles River Accelerator and Development Lab (CRADL™) on Binney Street in Cambridge, Massachusetts, and the addition of a second Cambridge location on Bent Street. CRADL provides flexible, ...
read more
Wednesday, February 14, 2018
Charles River Laboratories has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing adjustments.
read more
Charles River Laboratories International announced a collaboration with Arovella Therapeutics, a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS) services for cell characterization.
read more